AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimitip-MP 1 LS Tablet PR

Prescription Icon
Prescription Required

Marketer

Zodley Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (7.5mg)

Overview Glimitip-MP 1 LS Tablet PR

Metformin and glimepiride (Glimitip-MP 1 LS Tablet PR) is a dual-action oral medication managing blood glucose. In adults with type 2 diabetes, it complements diet and exercise to enhance glycemic control by improving insulin effectiveness and reducing blood sugar. Follow your physician's prescribed dosage and regimen. Take with food to minimize gastrointestinal discomfort. If a dose is missed, take it promptly unless the next dose is imminent; then, omit the missed dose. Never double a dose; overdose risks dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals elevates hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to use, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation. Kidney function will be assessed before treatment commences. Limit alcohol consumption to mitigate potential side effects.

Uses of Glimitip-MP 1 LS Tablet PR

Managing type 2 diabetes

Major Benefits of Glimitip-MP 1 LS Tablet PR:

Follow your doctor's instructions or consult the product label for guidance before administering. Take one Glimitip-MP 1 LS Tablet PR with a meal.

Common Side effects of Glimitip-MP 1 LS Tablet PR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Nausea
  • Diarrhea
  • Dizziness
  • Vomiting
  • Anemia (low number of red blood cells)
  • Weakness
  • Sinus infection

How to use Glimitip-MP 1 LS Tablet PR:

Follow your physician's instructions or consult the product labeling for proper administration. Glimitip-MP 1 LS Tablet PR should be ingested with a meal.

How Glimitip-MP 1 LS Tablet PR works:

Glimitip-MP 1 LS Tablet PR combines three distinct antidiabetic agents: glimepiride, metformin, and pioglitazone. This triple therapy optimizes blood glucose management when single or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts via multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Glimitip-MP 1 LS Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimitip-MP 1 LS Tablet PR during pregnancy might pose risks. While human research is scant, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible dangers before recommending its use. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glimitip-MP 1 LS Tablet PR while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimitip-MP 1 LS Tablet PR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is essential. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimitip-MP 1 LS Tablet PR cautiously, potentially requiring dosage modification. Consult a physician before use. Glimitip-MP 1 LS Tablet PR is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Glimitip-MP 1 LS Tablet PR :

Should you forget to take a Glimitip-MP 1 LS Tablet PR, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimitip-MP 1 LS Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimitip-MP 1 LS Tablet PR

Consuming alcohol while taking Glimitip-MP 1 LS Tablet PR is unsafe. Alcohol can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Consult your doctor before taking Glimitip-MP 1 LS Tablet PR if you have congestive heart failure, kidney or liver problems, or eye swelling. Also inform your doctor if you are pregnant, breastfeeding, or premenopausal, and about all medications you are taking, including prescription and over-the-counter drugs, vitamins, and herbal supplements.
Metformin, a component of Glimitip-MP 1 LS Tablet PR, can lead to vitamin B12 deficiency with prolonged use due to impaired absorption in the stomach.
Glimitip-MP 1 LS Tablet PR can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed or delayed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial, and carrying a readily available sugar source, such as candy or chocolate, is recommended.
Store this medication in its original, tightly closed container, as directed on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimitip-MP 1 LS Tablet P...
52
MRP 60
13% off